Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,250 shares at $155.80 ($540K) on 2018-01-16, disclosed to the SEC on 2018-01-17.
Scheduled sale ($540k) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.87 | 2,125 | $206K | 38.1% |
| 2 | $155.80 | 825 | $129K | 23.8% |
| 3 | $157.02 | 400 | $63K | 11.6% |
| 4 | $158.11 | 400 | $63K | 11.7% |
| 5 | $159.29 | 500 | $80K | 14.7% |
| Total | $127.08 avg | 4,250 |
| $540K |
| 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |